Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Jelic
S
S
Institute of Oncology and Radiology, Belgrade, Serbia.
Sotiropoulos
G C
GC
D006528:Carcinoma, Hepatocellular / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D005060:Europe / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D016031:Liver Transplantation; D008297:Male; D009367:Neoplasm Staging; D016019:Survival Analysis; D016896:Treatment Outcome; D000509:alpha-Fetoproteins / Q000032:analysis
D000509:alpha-Fetoproteins